Extrawell Pharmaceutical Holdings Ltd

00858

Company Profile

  • Business description

    Extrawell Pharmaceutical Holdings Ltd is an investment holding company. The company's operating segment includes Manufacturing, Trading, and Gene Development. It generates maximum revenue from the Manufacturing segment. The manufacturing segment is engaged in the development, manufacture, and sales of pharmaceutical products. Its trading segment is engaged in the marketing and distribution of imported pharmaceutical products. Geographically, it derives a majority of its revenue from China.

  • Contact

    979 King’s Road
    Suites 2206-08, 22nd Floor
    Devon House, Taikoo Place
    Quarry Bay
    Hong Kong
    HKG

    T: +852 28561918

    http://www.extrawell.com.hk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    161

Stocks News & Analysis

stocks

Lower production and higher prices for ASX hydrocarbon play

Improving pricing offsets severe weather impact on sales volumes.
stocks

Alphabet returns on AI investments accelerating

AI propels business across aegments, cloud is grightest; Increasing our fair value.
stocks

We lift our fair value estimate for this ASX energy play

Strong oil and LNG prices are a major win, though we don’t think they will stay high in the long term.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,887.6017.100.19%
CAC 408,114.840.000.00%
DAX 4024,292.38337.821.41%
Dow JONES (US)49,652.14790.331.62%
FTSE 10010,378.82165.711.62%
HKSE25,776.53335.31-1.28%
NASDAQ24,892.31219.070.89%
Nikkei 22559,284.92632.54-1.06%
NZX 50 Index12,903.31133.011.04%
S&P 5007,209.0173.061.02%
S&P/ASX 2008,665.8025.600.30%
SSE Composite Index4,112.164.650.11%

Market Movers